`
`
`
`
`
`
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`
`
`
`
`
`
`REGENERON PHARMACEUTICALS, INC.,
`Petitioner,
`
`v.
`
`NOVARTIS PHARMA AG,
`NOVARTIS TECHNOLOGY LLC,
`NOVARTIS PHARMACEUTICALS CORPORATION,
`Patent Owner.
`
`
`
`
`
`
`
`
`
`
`
`IPR2021-00816
`U.S. Patent No. 9,220,631
`
`
`
`
`
`
`PETITIONER’S REQUEST FOR ORAL ARGUMENT
`
`
`
`
`
`
`Pursuant to 37 C.F.R. § 42.70 and the Board’s Scheduling Order (Paper No.
`
`14), Petitioner Regeneron Pharmaceuticals, Inc. respectfully submits this Request
`
`for Oral Argument. The Board has scheduled the oral hearing for July 21, 2022 at
`
`11:30 AM EST. Petitioner and Patent Owner have conferred, and both prefer an
`
`in-person hearing. Petitioner also requests that an audio dial-in be available for
`
`corporate representatives to listen to the hearing remotely.
`
`
`
`Petitioner specifies the following issues to be argued:
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`The obviousness of claims 1-3, 5-9, 14-22, and 24 under 35 U.S.C. §
`103 based on WO 2011/006877 (“Sigg”) in view of WO 2009/030976
`(“Boulange”);
`
`The obviousness of claims 1-3, 5-9, 14-22, and 24 under 35 U.S.C. §
`103 based on WO 2008/077155 (“Lam”) in view of Boulange;
`
`The obviousness of claims 4, 10, and 23 under 35 U.S.C. § 103 based
`on Sigg in view of Boulange and Fries;
`
`The obviousness of claims 4, 10, and 23 under 35 U.S.C. § 103 based
`on Lam in view of Boulange and Fries;
`
`The obviousness of claims 11-13 under 35 U.S.C. § 103 based on
`Sigg in view of Boulange and WO 2007/149334 (“Furfine”);
`
`The obviousness of claims 11-13 under 35 U.S.C. § 103 based on
`Lam in view of Boulange and Furfine;
`
`The obviousness of claim 25 under 35 U.S.C. § 103 based on Sigg in
`view of Boulange and the 2008 Macugen Label;
`
`The obviousness of claim 25 under 35 U.S.C. § 103 based on Lam in
`view of Boulange and the 2008 Macugen Label;
`
`The obviousness of claim 26 under 35 U.S.C. § 103 based on Sigg in
`view of Boulange and Dixon;
`
`
`
`1
`
`
`
`
`
`
`
`
`
`The obviousness of claim 26 under 35 U.S.C. § 103 based on Lam in
`view of Boulange and Dixon;
`
`Rebuttal to Patent Owner’s presentation on all matters;
`
`Any additional issues on which the Board seeks clarification or deems
`necessary for issuing a Final Written Decision.
`
`
`
`Petitioner requests forty-five minutes to address the issues identified above
`
`and any related issues identified in Patent Owner’s Request for Oral Argument. To
`
`the extent the Board schedules the hearing to last more than ninety minutes,
`
`Petitioner requests that it be given half the length of the hearing to address these
`
`issues.
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`2
`
`
`
`Respectfully submitted,
`
`/Anish R. Desai/ x
`Anish R. Desai (Reg. No. 73,760)
`Elizabeth S. Weiswasser (Reg. No. 55,721)
`Natalie Kennedy (Reg. No. 68,511)
`Weil, Gotshal & Manges LLP
`767 Fifth Avenue
`New York, NY 10153
`Anish.Desai@weil.com
`Elizabeth.Weiswasser@weil.com
`Natalie.Kennedy@weil.com
`
`Christopher M. Pepe (Reg. No. 73,851)
`Matthew D. Sieger (Reg. No. 76,051)
`Priyata Y. Patel (Reg. No. 76,861)
`Weil, Gotshal & Manges LLP
`2001 M Street, N.W., Suite 600
`Washington, DC 20036
`Christopher.Pepe@weil.com
`Matthew.Sieger@weil.com
`Priyata.Patel@weil.com
`
`
`
`
`
`
`Counsel for Petitioner Regeneron
`Pharmaceuticals, Inc.
`
`
`
`Date: June 14, 2022
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`3
`
`
`
`CERTIFICATE OF SERVICE
`
`The undersigned hereby certifies that on June 14, 2022 the foregoing
`PETITIONER’S REQUEST FOR ORAL ARGUMENT was served via
`electronic mail, upon the following:
`
`
`Elizabeth J. Holland
`Daniel P. Margolis
`Allen & Overy LLP
`1221 Avenue of the Americas
`New York, NY 10020
`elizabeth.holland@allenovery.com
`daniel.margolis@allenovery.com
`
`Nicholas K. Mitrokostas
`John T. Bennett
`Allen & Overy LLP
`1 Beacon Street
`Boston, MA 02108
`nicholas.mitrokostas@allenovery.com
`john.bennett@allenovery.com
`
`William G. James
`Allen & Overy LLP
`1101 New York Avenue, NW
`Washington, D.C. 20005
`william.james@allenovery.com
`
`Linnea Cipriano
`Goodwin Procter LLP
`620 Eighth Avenue
`New York, NY 10018
`lcipriano@goodwinlaw.com
`
`
`
`
`
`
`
`
`4
`
`
`
`
`
`
`
`
`
`
`
`
`
`Duncan Greenhalgh
`Josh Weinger
`Goodwin Proctor LLP
`100 Northern Avenue
`Boston, MA 02210
`dgreenhalgh@goodwinlaw.com
`jweinger@goodwinlaw.com
`
`
`
`
`
`
`/Ryan Sotnick/
`Ryan Sotnick
`IP Paralegal
`Weil, Gotshal & Manges LLP
`2001 M Street, NW, Suite 600
`Washington, D.C. 20036
`T: 202-682-7000
`ryan.sotnick@weil.com
`
`5
`
`
`
`
`
`